Aehr Test Systems filings document material events, operating results, capital actions and governance matters for a semiconductor test and burn-in equipment company. Recent Form 8-K disclosures include quarterly financial-result releases covering revenue, bookings, backlog, cash position and GAAP and non-GAAP earnings measures.
The filing record also includes capital-structure disclosures tied to an at-the-market common stock offering under a Form S-3 registration statement, along with proxy and annual meeting materials. Those governance filings address director elections, shareholder voting results, amendments to the company’s equity incentive and employee stock purchase plans, auditor ratification and executive-compensation matters.
AEHR Industries filed a Form 144 reporting proposed/resale and recent sales activity in its common stock. The filing lists multiple restricted stock vesting events in 2024 (examples: 1,535 shares on 07/14/2024, 899 shares on 10/11/2024) and shows recent sales by Vernon I. Rogers: 10,888 shares on 04/10/2026 for $762,160.00 and 20,000 shares on 04/16/2026 for $1,645,143.50. The filing also lists a broker entry with 5,000 shares and $450,000.00 referenced under securities information.
Aehr Test Systems director Fariba Danesh exercised options and sold shares in a linked transaction. Danesh exercised 8,000 Non-Qualified Options for Common Stock at $2.25 per share, then sold 8,000 Common shares at an average price of $82.63 on the same date.
After these transactions, Danesh directly holds 13,143 Common shares, and the reported amount includes shares subject to unvested restricted stock units. No derivative options remain from this specific grant following the exercise.
AEHR Test Systems director Rhea J. Posedel reported an open-market sale of 7,500 shares of Common Stock on April 17, 2026 at $82.00 per share, executed through an account held indirectly "By Trust". After this transaction, the trust still holds 404,479 shares, and Posedel also reports 71,163 shares held directly. A footnote notes that these reported amounts include shares subject to unvested restricted stock units.
AEHR TEST SYSTEMS director Howard T. Slayen sold 25,000 shares of Common Stock in an open-market transaction at $85.00 per share. After this sale, he directly holds 178,328 shares. The reported holdings include shares subject to unvested restricted stock units, which may vest over time under company equity award terms.
Aehr Test Systems director Laura Oliphant reported an open-market sale of 1,716 shares of Common Stock on April 16, 2026 at $81.54 per share. After this transaction, she directly held 16,716 shares, and this amount includes shares subject to unvested restricted stock units.
AEHR TEST SYSTEMS executive Vernon Rogers, Executive VP of Sales & Marketing, reported an open-market sale of company common stock. On April 16, 2026, he sold 5,000 shares at $86.88 per share. Following this transaction, he directly holds 161,633 shares, which include shares subject to unvested restricted stock units.
AEHR Test Systems VP Alistair N. Sporck sold shares in the company. On April 16, 2026, he executed an open-market sale of 2,000 shares of common stock at $81.8800 per share. After this sale, he directly holds 20,635 shares and indirectly holds 7,177 shares through a trust.
A footnote explains that the reported amounts include shares subject to unvested restricted stock units, meaning some of his reported holdings are still vesting and not yet fully unrestricted.
Rhea J Posedel reported sales of Common Stock. The filing lists three transactions: 02/13/2026 sale of 13,998 shares for $390,404.22, 04/09/2026 sale of 30,000 shares for $2,100,000.00, and 04/16/2026 sale of 15,000 shares for $1,210,743.00.
Charles Schwab Corporation submitted a Form 144 notice reporting a proposed sale of Common stock. The filing lists Restricted Stock Units of 470 and shares from an ESPP of 530 as covered securities. The form date shown is 04/17/2026 and the listing venue is NASDAQ.
AEHR Test Systems director Laura Oliphant reported an indirect sale of 4,665 shares of Common Stock at an average price of $85.5879 per share. The shares were held by a trust, and this transaction reduced that indirect position to zero shares. After the sale, she continues to hold 18,432 shares directly, which include shares subject to unvested restricted stock units.